Early type I interferon‐mediated signals on B cells specifically enhance antiviral humoral responses
European Journal of Immunology 36(8): 2094-2105
Article 2006 English
Authors
KF
Katja Fink
KL
Karl S. Lang
NM
Nataly Manjarrez‐Orduño
Abstract
1 min read
Type I interferons (IFN-I) limit viral spread by inducing antiviral genes in infected target cells and by shaping the adaptive response through induction of additional cytokines. Vesicular stomatitis virus (VSV) efficiently triggers the production of IFN-I in mice, and it is suggested that IFN-alpha is induced after binding of VSV to TLR7 in infected cells. Our study with virus-specific B cell receptor-transgenic mice demonstrates here that IFN-I directly fuel early humoral immune responses in vivo. VSV-specific B cells that lacked IFN-alpha/beta receptors were considerably impaired in plasma cell formation and in generating antiviral IgM. At low viral titers, production of IFN-alpha following VSV infection was independent of TLR7-mediated signals. Interestingly, however, TLR7 ligation in B cells increased the formation of early antiviral IgM. These findings indicate that IFN-alpha-mediated augmentation of specific B cell responses is a partially TLR7- and virus dose-dependent mechanism.
Kindra M. Kelly‐Scumpia, Philip O. Scumpia, Jason S. Weinstein, Matthew J. Delano, Alex G. Cuenca, Dina C. Nacionales, James L. Wynn, Pui Y. Lee, Yutaro Kumagai, Philip A. Efron, Akira Shizuo, Clive Wasserfall, Mark A. Atkinson, Lyle L. Moldawer
Andrea Schuessler, Anneke Funk, Helen M. Lazear, Daphne Cooper, Shessy Torres, Stéphane Daffis, Babal K. Jha, Yutaro Kumagai, Osamu Takeuchi, Paul J. Hertzog, Robert H. Silverman, Akira Shizuo, David J. Barton, Michael Diamond, Alexander A. Khromykh
Sophia Davidson, Gerard E. Kaiko, Zhixuan Loh, Amit Lalwani, Vivian Zhang, Kirsten Spann, Shen Yun Foo, Nicole G. Hansbro, Satoshi Uematsu, Akira Shizuo, Klaus I. Matthaei, Helene F. Rosenberg, Paul S. Foster, Simon Phipps
Discussion(0)
No comments yet. Be the first to comment.